Architect i immunoassay systems

Abbott Has Received CE Mark Approval for Architect Hba1c Assay
Jul 11, 2012
Abbott has received CE mark approval for Architect HbA1c assay, designed to monitor treatment efficacy for diabetes patients. The chemiluminescent microparticle Architect HbA1c assay, which is designed for the quantitative determination ...

Tags: Architect HbA1c assay, Architect i immunoassay systems